The second largest drug distributor in the U.S. held steady on this year’s list with 6.9% revenue growth in its 2019 fiscal year, driven primarily by strong sales of pricey specialty drugs. Profits were down due to impairment charges taken on PharMEDium, the company’s troubled compounding unit; AmerisourceBergen announced it was shuttering the business earlier this year. Like its competitors, AmerisourceBergen faces thousands of lawsuits and a federal criminal investigation over its alleged role in the nation’s opioid epidemic. States rejected a proposed $18 billion settlement with the three major drug wholesalers in February.
Lists ranking AmerisourceBergen
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...view in list
Latest news for AmerisourceBergen
- Health4 Drug Giants Reach $260 Million Settlement in Ohio Opioid Case. What Happens Next?October 21, 2019 5:27 PM UTC
- LeadershipAmerisource CEO Doubts Amazon will be a “Significant Force” in Drug IndustryAugust 2, 2018 1:54 PM UTC
- HealthWhat Is AmerisourceBergen and Why Does Walgreens Want to Buy It?February 13, 2018 11:26 AM UTC